4D Molecular Therapeutics, Inc. (FDMT): Nilai perusahaan marang pendapatan

Logo korporat perusahaan 4D Molecular Corp (FDMT)

4D Molecular Therapeutics is driving innovation through its focus on patents and the recruitment of leading geneticists via generous R&D budgets. The current EV/Sales ratio reflects the business valuation dynamics excluding debt, with the latest mark standing at 3495.84. This enables the development of cardiac gene therapies in the US, leveraging substantial cash reserves to fund costly clinical trials.

Koefisien nilai perusahaan marang pendapatan 4D Molecular Therapeutics Inc (FDMT): kanggo periode 23.11.2025 - 20.11.2026

Rincian metrik komprehensif lan analitis 4D Molecular Therapeutics Inc (FDMT)

- indikator dhuwit lan ilining kas:
Analisis fundamental perusahaan:FDMT - 4D Molecular Therapeutics
Produk seri 4DMT

4D Molecular Therapeutics occupies a protected niche thanks to its proprietary genetic vector platform and high FDA barriers to entry. The EV/Sales multiple measures the total value of the business, including debt, per unit of revenue, excluding the influence of capital structure. By analyzing the EV/Sales multiple trend, an investor can discern the market valuation of future sales potential. This chart reflects the degree of asset speculation or undervaluation. This confirms the fundamental resilience of 4D Molecular Therapeutics within the capital-intensive biotechnology sector.

Analisis pesaing 4D Molecular Therapeutics

TEM (tempus.com) - Rasio nilai perusahaan marang pendapatan|qiagen.com (QGEN) - Rasio nilai perusahaan marang pendapatan|Ionis (IONS) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Repligen|Avidity (RNA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales CRSP|Rasio total nilai perusahaan marang pendapatan GeneDx|Rasio nilai perusahaan marang pendapatan Ultragenyx RARE|Rasio total nilai perusahaan marang pendapatan Beam Therapeutics (BEAM)|SRPT: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Twist Bioscience|TXG (10x Genomics) - Nilai perusahaan marang pendapatan|Intellia Therapeutics, Inc. (NTLA) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Stoke Therapeutics Inc|BLFS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan WVE (Wave Life Sciences Corp)|Rasio total nilai perusahaan marang pendapatan Maze Therapeutics Corp|Sionna Therapeutics Inc - Nilai perusahaan marang pendapatan|PRME (primemedicine.com) - Nilai perusahaan marang volume dodolan|TSHA - Rasio nilai perusahaan marang pendapatan|QURE (uniQure) - Rasio nilai perusahaan marang pendapatan|MeiraGTx Corp (MGTX) - Rasio nilai perusahaan marang pendapatan|Regenxbio - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan solidbio.com|Multiplikator nilai perusahaan marang pendapatan ocugen.com OCGN|Multiplikator EV/Sales PACB|Benitec - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Design Therapeutics DSGN|Multiplikator EV/Sales Rocket Pharmaceuticals RCKT|LXEO - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Korro Bio Inc.|EDIT: Multiplikator EV/Sales|SLN - Rasio total nilai perusahaan marang pendapatan|PRQR (ProQR Therapeutics) - Multiplikator EV/Sales|codexis.com (CDXS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales SGMO|Multiplikator EV/Sales Nautilus Biotechnology, Inc. (NAUT)|Multiplikator EV/Sales MGX (Metagenomi Inc.)|Nilai bisnis marang pendapatan DTIL|Generation Bio Co. - Multiplikator EV/Sales|BOLD: Rasio nilai perusahaan marang pendapatan|XCUR (Exicure, Inc.) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan IMNN|Rasio nilai perusahaan marang pendapatan RXi Pharmaceuticals|mustangbio.com (MBIO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan TransCode (RNAZ)|Bionano Genomics Inc. - Rasio nilai perusahaan marang pendapatan|Applied DNA Sciences - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan bluebirdbio.com (BLUE)|IPA - Rasio nilai perusahaan marang pendapatan|OMGA - Multiplikator EV/Sales|OMIC (Singular Genomics Systems, Inc.) - Nilai perusahaan marang pendapatan|Regulus Therapeutics Inc - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Syros Pharmaceuticals|Nilai perusahaan marang pendapatan Telesis Bio (TBIO)|Multiplikator EV/Sales TCON|UBX - Multiplikator nilai perusahaan marang pendapatan